Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08PCH
|
|||
Former ID |
DIB005916
|
|||
Drug Name |
Javelin
|
|||
Synonyms |
MJV-101
Click to Show/Hide
|
|||
Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 3 | [1] | |
Company |
Antigenics
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C31H29F5N4O3
|
|||
Canonical SMILES |
CC(C)C1=CC=C(C=C1)NC(=O)N(C)C.C1=CC(=CC(=C1)OC2=C(C=CC=N2)C(=O)NC3=C(C=C(C=C3)F)F)C(F)(F)F
|
|||
InChI |
1S/C19H11F5N2O2.C12H18N2O/c20-12-6-7-16(15(21)10-12)26-17(27)14-5-2-8-25-18(14)28-13-4-1-3-11(9-13)19(22,23)24;1-9(2)10-5-7-11(8-6-10)13-12(15)14(3)4/h1-10H,(H,26,27);5-9H,1-4H3,(H,13,15)
|
|||
InChIKey |
RZSCFTDHFNHMOR-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 100920-69-2
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02395172) Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200). U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.